Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Germany

Marie Skłodowska-Curie Action · Running

INTROS Towards Innovative Treatments and Management Of Surgical and Burn Wounds

Coordinator
Mybiotech GmbH, Germany
Runs
1 November 2025 to 31 October 2029
Status
Running
EU funding
€2.3m
Total cost
—
Partners
12 organisations in 5 countries
Type
Marie Skłodowska-Curie Action
Grant agreement
101227378

What the project is doing

In the project's own words, from its summary on CORDIS.

The INTROS project, as multi- and interdisciplinary doctoral network, will develop diagnostic and prevention strategies for acute complex wounds that are at risk of infection. Infections represent a significant challenge, as they often require prolonged treatment and may even result in extended hospital stays. All this is associated with considerable burden to clinics and patients as well as financial costs. To address this issue, the doctoral candidates and consortium partners dedicate their efforts in creation of early diagnostic methods that can effectively detect infection and/or facilitate the direct application of advanced antimicrobial dressings and innovative formulations following burn or surgical procedures.

Additionally, the (bio)materials will be designed to prevent inflammation, promote healing and regeneration, thereby reducing the risk of infection and its associated complications such as scarring and impairments. The developed systems will consist of innovative nano-/micro-sized delivery systems, biodegradable and-compatible electrical sensors or patches based on hydrogels, bacterial nanocellulose and polyurethanes as well as biologically active extracellular vesicles.

This will be supported by extensive biocompatibility and efficacy testing in vitro, in vivo and especially in ex vivo wound models as well as in-depth physicochemical characterisation. Special emphasis will be on the scale-up to industrial levels and manufacturing towards GMP conditions already during the project’s lifetime. INTROS will contribute to bringing forward a new generation of young scientists by creating a research and training network for 8 Doctoral Candidates, equip them with multidisciplinary skills from biomaterials, nanotechnology, pharmaceutical chemistry and technology, biochemistry and material science.

Combined with extensive complementary soft/transferable skills, INTROS will enable them to take leading roles in industry and academia in the European community.

Topics

Who is involved

OrganisationCityCountryRole
Mybiotech GmbHUberherrnGermanyCoordinator
AnicellsNielBelgiumAssociatedpartner
Universiteit AntwerpenAntwerpenBelgiumAssociatedpartner
Vlaamse Instelling Voor Technologisch Onderzoek N.v.MolBelgiumParticipant
Charite - Universitaetsmedizin BerlinBerlinGermanyParticipant
Universitat Des SaarlandesSaarbruckenGermanyParticipant
I+med S CoopVitoria-GasteizSpainAssociatedpartner
Universidad Del Pais Vasco/ Euskal Herriko UnibertsitateaLeioaSpainParticipant
AB Medica SpAMilanoItalyParticipant
Universita Di PisaPisaItalyParticipant
MARIFARM, proizvodnja in storitve d.o.o.MariborSloveniaAssociatedpartner
Univerza V MariboruMariborSloveniaParticipant

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI